SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-127048
Filing Date
2021-10-18
Accepted
2021-10-18 11:34:49
Documents
13
Period of Report
2021-10-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2130392d1_8k.htm   iXBRL 8-K 26904
2 EXHIBIT 99.1 tm2130392d1_ex99-1.htm EX-99.1 10692
  Complete submission text file 0001104659-21-127048.txt   210964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arth-20211013.xsd EX-101.SCH 3213
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arth-20211013_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arth-20211013_pre.xml EX-101.PRE 22729
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2130392d1_8k_htm.xml XML 3286
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 211327703
SIC: 3841 Surgical & Medical Instruments & Apparatus